Condition: Acute Gouty Arthritis · Gout Flare · Gout Flares · Sponsor: Atom Therapeutics Co., Ltd
A randomized, double-blind, international multicenter, colchicine and placebo-controlled study to evaluate the efficacy and safety of ABP-745 in subjects with acute gout. Efficacy of ABP-745 in reducing pain and swelling compared with standard colchicine treatment and placebo will be evaluated in participants with acute gout. The primary efficacy measurement will be pain score after treatment.
This description comes directly from the study's public registry record.
Ullrich Schwertschlag, MD,PhD · 1-978-257-1926 · ullrich.schwertschlag@atombp.com
Always discuss trial participation with your own doctor first.
| Onyx Clinical Research | Peoria, Arizona, United States | Recruiting |
| Exinia Research | La Mesa, California, United States | Recruiting |
| Evergreen Clinical Trial | Norcross, Georgia, United States | Not Yet Recruiting |
| Bioluminux Clinical Research | Naperville, Illinois, United States | Recruiting |
| Exinia Research | Des Moines, Iowa, United States | Recruiting |
| Northshore Research Associates | Alexandria, Louisiana, United States | Recruiting |
| DelRicht Research | Baton Rouge, Louisiana, United States | Recruiting |
| DelRicht Research | New Orleans, Louisiana, United States | Recruiting |
| Interphase Clinical Trials | Lutherville, Maryland, United States | Recruiting |
| DelRicht Research Gulfport | Gulfport, Mississippi, United States | Recruiting |
| Albuquerque Clinical Trials, Inc. | Albuquerque, New Mexico, United States | Recruiting |
| West Clinical Research | Morehead City, North Carolina, United States | Not Yet Recruiting |
+ 26 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07145229